Syngene International Ltd vs Vijaya Diagnostic Centre Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Syngene International Ltd is ₹ 366.9 as of 23 Oct 15:30 . The P/E Ratio of Syngene International Ltd changed from 53.7 on March 2021 to 49.7 on March 2026 . This represents a CAGR of -1.28% over 6 yearsThe P/E Ratio of Vijaya Diagnostic Centre Ltd changed from 40.7 on March 2022 to 51.3 on March 2026 . This represents a CAGR of 4.74% over 5 years The Market Cap of Syngene International Ltd changed from ₹ 21734 crore on March 2021 to ₹ 15724 crore on March 2026 . This represents a CAGR of -5.25% over 6 yearsThe Market Cap of Vijaya Diagnostic Centre Ltd changed from ₹ 4463 crore on March 2022 to ₹ 8864 crore on March 2026 . This represents a CAGR of 14.71% over 5 years The revenue of Syngene International Ltd for the Jun '26 is ₹ 761.3 crore as compare to the Mar '26 revenue of ₹ 1058 crore. This represent the decline of -28.09% The revenue of Vijaya Diagnostic Centre Ltd for the Jun '26 is ₹ 239.51 crore as compare to the Mar '26 revenue of ₹ 221.78 crore. This represent the growth of 7.99% The ebitda of Syngene International Ltd for the Jun '26 is ₹ 102.6 crore as compare to the Mar '26 ebitda of ₹ 319.6 crore. This represent the decline of -67.9% The ebitda of Vijaya Diagnostic Centre Ltd for the Jun '26 is ₹ 107.07 crore as compare to the Mar '26 ebitda of ₹ 97.92 crore. This represent the growth of 9.34% The net profit of Syngene International Ltd changed from ₹ 75.7 crore to ₹ -9 crore over 9 quarters. This represents a CAGR of NaN% The net profit of Vijaya Diagnostic Centre Ltd changed from ₹ 31.51 crore to ₹ 53.1 crore over 9 quarters. This represents a CAGR of 26.10% The Dividend Payout of Syngene International Ltd changed from 10.18 % on March 2022 to 16.52 % on March 2026 . This represents a CAGR of 10.17% over 5 yearsThe Dividend Payout of Vijaya Diagnostic Centre Ltd changed from 9.44 % on March 2022 to 11.54 % on March 2026 . This represents a CAGR of 4.10% over 5 years .

About Syngene International Ltd

Syngene International Limited is an integrated research, development and manufacturing services organization serving global pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical sectors.
Headquartered in India, the operations are driven by its highly qualified teams comprising 5641 scientists and its state-of-the-art facilities, spread over 2.5 million sq. ft., across 3 locations in India: Bangalore, Hyderabad and Mangalore.
The Company operate into 4 business divisions comprising of Discovery Services, Development Services, Manufacturing Services and the Dedicated Centers. Syngene International Limited was incorporated at Bangalore in 1993.
The Company was promoted by Biocon and Kiran Mazumdar Shaw, a promoter of Biocon Limited.
The Company's health-related services extend across all major therapeutic areas and modalities.

About Vijaya Diagnostic Centre Ltd

Vijaya Diagnostic Centre Limited established in 1981, is a leading provider of diagnostic services in India.
With a steadfast commitment to delivering high quality, comprehensive diagnostic solutions, Vijaya has grown into the largest integrated diagnostic chain in Southern India.
Founded by Dr. S. Surendranath Reddy, the journey began to offer reliable and comprehensive diagnostic services under one roof.
Today, Company operate a vast network of 151+ diagnostic centres across 25+ cities, including Telangana, Andhra Pradesh, Maharashtra, Karnataka, West Bengal and the National Capital Region. Their state-of-the-art facilities are equipped with the latest technology, to offer a wide range of pathology and radiology services.
Company provides Corporate Wellness solutions.

FAQs for the comparison of Syngene International Ltd and Vijaya Diagnostic Centre Ltd

Which company has a larger market capitalization, Syngene International Ltd or Vijaya Diagnostic Centre Ltd?

Market cap of Syngene International Ltd is 14,810 Cr while Market cap of Vijaya Diagnostic Centre Ltd is 14,296 Cr

What are the key factors driving the stock performance of Syngene International Ltd and Vijaya Diagnostic Centre Ltd?

The stock performance of Syngene International Ltd and Vijaya Diagnostic Centre Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Syngene International Ltd and Vijaya Diagnostic Centre Ltd?

As of October 25, 2026, the Syngene International Ltd stock price is INR ₹366.9. On the other hand, Vijaya Diagnostic Centre Ltd stock price is INR ₹1388.05.

How do dividend payouts of Syngene International Ltd and Vijaya Diagnostic Centre Ltd compare?

To compare the dividend payouts of Syngene International Ltd and Vijaya Diagnostic Centre Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.